{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1010000781871288341.json","@type":"Article","resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"ja","@value":"Selective inhibition of NF-kB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo."}],"publication":{"prism:publicationName":[{"@language":"ja","@value":"Nature Medicine 10・6"}],"prism:publicationDate":"2004","prism:startingPage":"617","prism:endingPage":"624"},"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000781871288320","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"16209053"},{"@type":"JGN","@value":"JP16209053"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16209053/"}],"notation":[{"@language":"ja","@value":"骨リモデリングユニットを標的としたハイブリッド型新規薬物治療の開発"},{"@language":"en","@value":"Development of New Hybrid-type Drugs Targeted to the Mechanism of Bone Remodeling"}]}],"dataSourceIdentifier":[{"@type":"KAKEN","@value":"PRODUCT-18638189"}]}